Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Lymphoma Non-Hodgkin
- Pediatric Cancer
- Rituximab
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 1 years and 18 years
- Gender
- Both males and females
Description
Research purposes: To investigate the efficacy and safety of SCCCG-BL/DLBCL-2017 in children with BL and DLBCL. To investigate the effect of rituximab combined with chemotherapy on the survival rate of children with high-risk BL/DLBCL. To investigate the effect of rituximab on immune function in chi...
Research purposes: To investigate the efficacy and safety of SCCCG-BL/DLBCL-2017 in children with BL and DLBCL. To investigate the effect of rituximab combined with chemotherapy on the survival rate of children with high-risk BL/DLBCL. To investigate the effect of rituximab on immune function in children with high-risk BL/DLBCL. To explore the correlation between MRD detection and the efficacy and survival of children with BL/DLBCL. To explore the role of PET/CT in evaluating residual lesions in children after BL/DLBCL treatment.
Tracking Information
- NCT #
- NCT03958916
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sun Xiaofei, Master Sun Yat-sen University
Get Well Soon